|Bid||72.98 x 800|
|Ask||73.39 x 800|
|Day's Range||72.56 - 73.39|
|52 Week Range||50.10 - 75.10|
|Beta (3Y Monthly)||0.90|
|PE Ratio (TTM)||32.05|
|Earnings Date||May 29, 2019 - Jun 3, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||0.00|
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
Legendary investors such as Jeffrey Talpins and Seth Klarman earn enormous amounts of money for themselves and their investors by doing in-depth research on small-cap stocks that big brokerage houses don't publish. Small cap stocks -especially when they are screened well- can generate substantial outperformance versus a boring index fund. That's why we analyze the […]
By buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger returns, and build a portfolio ourselves. Just take a look at CorVel Corporation (NASDAQ:CRVL), which is up...
NEW YORK, Feb. 13, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
CorVel Corporation (NASDAQ: CRVL), reported that the Company’s Board of Directors has approved a 1,000,000 share expansion to its existing stock repurchase program, increasing the total number of shares approved for repurchase over the life of such program to 37,000,000 shares from the previous limit of 36,000,000 shares. Based upon the Company’s closing stock price on February 8, 2019, this increase in the number of shares authorized to be repurchased over time would cost approximately an additional $63 million if the full 1,000,000 additional shares are repurchased.
On a per-share basis, the Irvine, California-based company said it had net income of 54 cents. The health care management company posted revenue of $146.1 million in the period. CorVel shares have risen ...
IRVINE, Calif., Feb. 05, 2019 -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended December 31, 2018. Revenues for the quarter ended December 31,.
Today we'll evaluate CorVel Corporation (NASDAQ:CRVL) to determine whether it could have potential as an investment idea. Specifically, we'll consider its Return On Capital Employed (ROCE), since that will give Read More...
IRVINE, Calif., Jan. 22, 2019 -- Event: Quarterly Earnings Release Webcast Hosts: Gordon Clemons, Chairman Michael Combs, President and Chief Executive Officer.
CorVel Corporation (CRVL), announced today that its Board of Directors has promoted the Company’s President, Michael Combs, to also serve as its Chief Executive Officer, effective January 18, 2019. Mr. Combs was previously promoted to President in April 2017 and served as Chief Information Officer from April 2015 to April 2017. Mr. Combs has been with the Company for more than 27 years, joining the Company as a software engineer in October 1991.
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment that leads to companies swapping their equity for debt and focusing mostly on short-term performance such as beating the quarterly earnings estimates. In the fourth quarter, […]
The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To keep it practical, we’ll show how CorVel Corporation’s (NASDAQ:CRVL) P/E ratio Read More...
NEW YORK, Nov. 08, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
On a per-share basis, the Irvine, California-based company said it had profit of 67 cents. The health care management company posted revenue of $148.2 million in the period. CorVel shares have increased ...
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return Read More...
Analyzing CorVel Corporation’s (NASDAQ:CRVL) track record of past performance is a valuable exercise for investors. It enables us to reflect on whether or not the company has met expectations, whichRead More...